Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Seifert

Showing results (1-10 of 363) with videos related to

Pageof 37
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 26, 2016
Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuityRoland Seifert
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 6, 2021
How Naunyn-Schmiedeberg's Archives of Pharmacology deals with fraudulent papers from paper millsRoland Seifert
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 13, 2013
A door opener for future research: agonist-induced β3-adrenoceptor desensitization in HEK cells but not CHO cellsRoland Seifert
Structure (London, England : 1993)|October 6, 2016
Distinct Signaling Roles of cIMP, cCMP, and cUMPRoland Seifert
Hypertension (Dallas, Tex. : 1979)|April 29, 2015
Emerging Role of Phosphodiesterase 2A in HypertensionRoland Seifert
Deutsches Arzteblatt International|September 27, 2013
Correspondence (letter to the editor): Numerous errorsRoland Seifert
Trends in Biochemical Sciences|December 2, 2014
cCMP and cUMP: emerging second messengersRoland Seifert
Deutsches Arzteblatt International|December 20, 2018
Act Immediately Upon Onset of SymptomsRoland Seifert
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2016
Recent progress in the field of cIMP researchRoland Seifert
Biochemical Pharmacology|January 9, 2014
Vidarabine is neither a potent nor a selective AC5 inhibitorRoland Seifert
Pageof 37

Showing results (1-10 of 363) with videos related to

Sort By:
Pageof 37
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 26, 2016
Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuityRoland Seifert
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 6, 2021
How Naunyn-Schmiedeberg's Archives of Pharmacology deals with fraudulent papers from paper millsRoland Seifert
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 13, 2013
A door opener for future research: agonist-induced β3-adrenoceptor desensitization in HEK cells but not CHO cellsRoland Seifert
Structure (London, England : 1993)|October 6, 2016
Distinct Signaling Roles of cIMP, cCMP, and cUMPRoland Seifert
Hypertension (Dallas, Tex. : 1979)|April 29, 2015
Emerging Role of Phosphodiesterase 2A in HypertensionRoland Seifert
Deutsches Arzteblatt International|September 27, 2013
Correspondence (letter to the editor): Numerous errorsRoland Seifert
Trends in Biochemical Sciences|December 2, 2014
cCMP and cUMP: emerging second messengersRoland Seifert
Deutsches Arzteblatt International|December 20, 2018
Act Immediately Upon Onset of SymptomsRoland Seifert
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2016
Recent progress in the field of cIMP researchRoland Seifert
Biochemical Pharmacology|January 9, 2014
Vidarabine is neither a potent nor a selective AC5 inhibitorRoland Seifert
Pageof 37